Latest Cardiopulmonary bypass Stories

2014-09-09 08:31:27

MONMOUTH JUNCTION, N.J., Sept. 9, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a blood purification company using its CytoSorb® extracorporeal cytokine adsorber to prevent or treat organ failure in life-threatening conditions, announced its U.S. Cardiac Surgery Advisory Board (CSAB) that includes leaders in cardiothoracic surgery, surgical critical care, extracorporeal therapy, and inflammation. The Board will oversee the use of CytoSorb® in cardiac surgery trials...

2014-04-17 16:27:22

MEMPHIS, Tenn., April 17, 2014 /PRNewswire-USNewswire/ -- More than 20 percent of Le Bonheur Children's Hospital's open heart surgeries are now bloodless, meaning no blood or blood products given during surgery. The Memphis, Tenn., hospital's Heart Institute has been taking aggressive steps to minimize blood loss during surgery and reduce perioperative blood transfusions over the last 18 months. http://photos.prnewswire.com/prnvar/20140417/76284 "Blood transfusions increase a...

2013-05-16 23:24:24

ECMO transport program allows hospital to treat more complex patients from outside region. St. Louis, MO (PRWEB) May 16, 2013 On September 20, 2012, Brandie and Dustin Stoddard welcomed their second baby girl into the world. Haevyn Delanie weighed-in at a healthy seven pounds, two ounces, was 18 inches long, and went home right on schedule. Just four months later, though, her family was back in the hospital. This time, they were in Kansas City, waiting for a team of medical professionals...

2013-05-07 10:55:12

First use of pumpless paracorporeal assist device in the very young, presentation at 93rd AATS Annual Meeting Adults with end-stage respiratory failure and pulmonary hypertension requiring ECMO (extracorporeal membrane oxygenation) have been "bridged" toward lung transplantation with novel lung assist devices such as the Novalung. This and related devices work based on pumpless application of oxygenators. A presentation by David M. Hoganson, MD, and colleagues from Washington University...

2012-07-25 23:02:27

Respected medical researchers develop advancements in cardiopulmonary bypass, a key technology used in heart operations. Chevy Chase, MD (PRWEB) July 25, 2012 The Medici Portfolio, LLC today announced that Airmid IP LLC, a Medici managed company, seeks to license a patent portfolio generally related to perfusion circuits used to keep patients alive during cardiopulmonary bypass surgery. The patents cover inventions of two respected American clinicians and researchers in the field of...

2012-06-27 22:49:06

Oxygen microparticles could deliver oxygen when breathing is impaired Patients unable to breathe because of acute lung failure or an obstructed airway need another way to get oxygen to their blood–and fast–to avoid cardiac arrest and brain injury. A team led by researchers at Boston Children's Hospital has designed tiny, gas-filled microparticles that can be injected directly into the bloodstream to quickly oxygenate the blood. The microparticles consist of a single layer of...

Latest Cardiopulmonary bypass Reference Libraries

Extracorporeal Membrane Oxygenation
2013-04-30 13:11:12

Extracorporeal Membrane Oxygenation, also known as ECMO, is best described as long term life support occurring outside the patient’s body. It should be noted, however, that ECMO is temporary and typically lasts three to ten days on average. ECMO is a means of oxygenating blood without it having to circulate inside the body, and thus allows time for essential recovery of the heart and lungs. ECMO comes with many serious risks and is only used in severe cases of cardiac or respiratory failure...

More Articles (1 articles) »
Word of the Day
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.